24 Jul Date July 24, 2025 Author TelaraPharma Tags Arch Biopartners, renal injury, The Cilastatin project Arch Biopartners Announces Start of Patient Recruitment in Phase II PONTIAK Trial Targeting Drug-Toxin-Related Acute Kidney Injury (AKI) We at Telara Pharma are thrilled to see our partner Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB) announce the start of patient r...
24 Nov Date November 24, 2020 Author TelaraPharma Tags Dr. Alberto Tejedor, Gregorio Marañon, renal injury Birth of Telara Pharma S.L. Telara Pharma S.L. has been created in Madrid (Spain), acquiring a license agreement with Gregorio Marañón Health Research insti...